Regeneron Pharmaceuticals (REGN) - 27 Year Stock Price History

Historical daily stock prices for Regeneron Pharmaceuticals since 1991 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Regeneron Pharmaceuticals (REGN) as of March 22, 2018 is 327.69.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $35.291B $5.872B
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.